In the previous 2 articles (linked below) we have looked at what the Quality Management System (QMS) of the near future (Quality 4.0) may look like under MTP 4.0 (Industry 4.0 for the Medical Technology, Biotechnology and Pharmaceutical sector).
Recall that, MTP 4.0 is a holistic operating model that incorporates digital technologies, data...
We're excited to announce the first list of confirmed speakers for our Symposium to be held in Singapore on 16 - 17 March 2017: A Global Perspective on Effective Management of Risk-based GMP for Health Products.
As part of our commitment to the local biotech sector, SeerPharma was proud to sponsor a BioMelbourne Network session on Corporate Culture and Risk earlier this year.
When handling a pharmaceutical or medical device, it is imperative in the eyes of the regulator, such as the TGA or FDA, that people within your organisation are assigned appropriate roles and responsibilities. One of the most important roles is that of the Authorised Person, who is responsible for authorising steps of the manufacturing process,...
Copyright © SeerPharma
